Spoken Alpha · Executive

John P. Reed

EVP, Innovative Medicine, R&DJNJJOHNSON & JOHNSON

Current

Tracked since Feb 15, 2024

Tracked across 47 earnings calls in our data since 2021.

Role timeline

JNJJOHNSON & JOHNSON
Current
EVP, Innovative Medicine, R&D
Feb 15, 2024 – Present · source: edgar_form4
JNJJOHNSON & JOHNSON
EVP, Pharmaceuticals R&D
Apr 3, 2023 – May 1, 2023 · source: edgar_form4
ARHSArhaus, Inc.
CEO and Chairman
Dec 10, 2021 – Dec 31, 2023 · source: edgar_form5
ARHSArhaus, Inc.
CHIEF EXECUTIVE OFFICER
Nov 3, 2021 – Nov 3, 2021 · source: edgar_form3
CPAYCORPAY, INC.
Global Chief Information Offic
Jan 21, 2015 – May 5, 2017 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

47 calls

ARHSQ2 FY2026Aug 6, 2026

Arhaus, Inc.

JNJQ2 FY2026Jul 15, 2026

JOHNSON & JOHNSON

ARHSQ1 FY2026May 7, 2026

Arhaus, Inc.

JNJQ1 FY2026Apr 14, 2026

JOHNSON & JOHNSON

ARHSQ4 FY2025Feb 26, 2026

Arhaus, Inc.

JNJ